Last updated: 23 January 2018 at 11:18pm EST

Jacqueline Northcut Net Worth




The estimated Net Worth of Jacqueline Northcut is at least $2.4 Tausend dollars as of 5 May 2017. Ms Northcut owns over 1,000 units of Moleculin Biotech Inc stock worth over $2,400 and over the last 8 years she sold MBRX stock worth over $0.

Ms Northcut MBRX stock SEC Form 4 insiders trading

Ms has made over 1 trades of the Moleculin Biotech Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently she bought 1,000 units of MBRX stock worth $820 on 5 May 2017.

The largest trade she's ever made was buying 1,000 units of Moleculin Biotech Inc stock on 5 May 2017 worth over $820. On average, Ms trades about 500 units every 0 days since 2016. As of 5 May 2017 she still owns at least 1,000 units of Moleculin Biotech Inc stock.

You can see the complete history of Ms Northcut stock trades at the bottom of the page.





Ms. Jacqueline Northcut biography

Jacqueline Northcut is the Consultant at Moleculin Biotech Inc.



How old is Ms Northcut?

Ms Northcut is 59, she's been the Consultant of Moleculin Biotech Inc since . There are 8 older and 2 younger executives at Moleculin Biotech Inc. The oldest executive at Moleculin Biotech Inc is Dr. Donald H. Picker Ph.D., 75, who is the Chief Scientific Officer.

What's Ms Northcut's mailing address?

Jacqueline's mailing address filed with the SEC is C/O MOLECULIN BIOTECH, INC., 2575 WEST BELLFORT, SUITE 333, HOUSTON, TX, 77054.

Insiders trading at Moleculin Biotech Inc

Over the last 8 years, insiders at Moleculin Biotech Inc have traded over $340,000 worth of Moleculin Biotech Inc stock and bought 433,338 units worth $371,310 . The most active insiders traders include Walter V Klemp, John M Climaco und Waldemar Priebe. On average, Moleculin Biotech Inc executives and independent directors trade stock every 75 days with the average trade being worth of $69,293. The most recent stock trade was executed by Walter V Klemp on 2 July 2024, trading 982 units of MBRX stock currently worth $2,357.



What does Moleculin Biotech Inc do?

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient’s own immune system. the other portfolio targets the metabolism of tumors.



What does Moleculin Biotech Inc's logo look like?

Moleculin Biotech Inc logo

Complete history of Ms Northcut stock trades at Moleculin Biotech Inc

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
5 May 2017 Jacqueline Northcut
Direktor
Kauf 1,000 $0.82 $820
5 May 2017
1,000


Moleculin Biotech Inc executives and stock owners

Moleculin Biotech Inc executives and other stock owners filed with the SEC include: